Biopharmaceutical CMO and CRO Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Biopharmaceutical CMO and CRO Market

1.1. Definition and Scope

1.1.1. Definition of Biopharmaceutical CMO and CRO

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Biopharmaceutical CMO and CRO Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Biopharmaceutical CMO and CRO Market By Source

1.2.3. Biopharmaceutical CMO and CRO Market By Service Type

1.2.4. Biopharmaceutical CMO and CRO Market By Product

1.2.5. Biopharmaceutical CMO and CRO Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Biopharmaceutical CMO and CRO Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Biopharmaceutical CMO and CRO Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

CHAPTER 5. Biopharmaceutical CMO and CRO Market By Source

5.1. Introduction

5.2. Biopharmaceutical CMO and CRO Revenue By Source

5.2.1. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast, By Source, 2020-2032

5.2.2. Non-Mammalian

5.2.2.1. Non-Mammalian Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Mammalian

5.2.3.1. Mammalian Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Biopharmaceutical CMO and CRO Market By Service Type

6.1. Introduction

6.2. Biopharmaceutical CMO and CRO Revenue By Service Type

6.2.1. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast, By Service Type, 2020-2032

6.2.2. Contract Manufacturing

6.2.2.1. Contract Manufacturing Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.2. Process Development

6.2.2.2.1. Process Development Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.2.2. Upstream

6.2.2.2.2.1. Upstream Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.2.3. Downstream

6.2.2.2.3.1. Downstream Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.3. Analytical & QC studies

6.2.2.3.1. Analytical & QC studies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.4. Finish & Fill Operations

6.2.2.4.1. Finish & Fill Operations Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.5. Packaging

6.2.2.5.1. Packaging Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Contract Research

6.2.3.1. Contract Research Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.2. Oncology

6.2.3.2.1. Oncology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.3. Cardiology

6.2.3.3.1. Cardiology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.4. Neuroscience

6.2.3.4.1. Neuroscience Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.5. Inflammation & Immunology

6.2.3.5.1. Inflammation & Immunology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.6. Others

6.2.3.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Biopharmaceutical CMO and CRO Market By Product

7.1. Introduction

7.2. Biopharmaceutical CMO and CRO Revenue By Product

7.2.1. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast, By Product, 2020-2032

7.2.2. Biosimilars

7.2.2.1. Biosimilars Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Biologics

7.2.3.1. Biologics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3.2. Monoclonal Antibodies (MAbs)

7.2.3.2.1. Monoclonal Antibodies (MAbs) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3.3. Recombinant Proteins

7.2.3.3.1. Recombinant Proteins Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3.4. Vaccines

7.2.3.4.1. Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3.5. Antisense, RNAi, & Molecular Therapy

7.2.3.5.1. Antisense, RNAi, & Molecular Therapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3.6. Others

7.2.3.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Biopharmaceutical CMO and CRO Market By Country 

8.1. North America Biopharmaceutical CMO and CRO Market Overview

8.2. U.S.

8.2.1. U.S. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

8.2.2. U.S. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

8.2.3. U.S. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

8.3. Canada

8.3.1. Canada Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

8.3.2. Canada Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

8.3.3. Canada Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Biopharmaceutical CMO and CRO Market By Country

9.1. Europe Biopharmaceutical CMO and CRO Market Overview

9.2. U.K.

9.2.1. U.K. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

9.2.2. U.K. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

9.2.3. U.K. Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

9.3. Germany

9.3.1. Germany Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

9.3.2. Germany Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

9.3.3. Germany Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

9.4. France

9.4.1. France Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

9.4.2. France Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

9.4.3. France Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

9.5. Spain

9.5.1. Spain Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

9.5.2. Spain Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

9.5.3. Spain Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

9.6.2. Rest of Europe Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

9.6.3. Rest of Europe Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Biopharmaceutical CMO and CRO Market By Country

10.1. Asia Pacific Biopharmaceutical CMO and CRO Market Overview

10.2. China

10.2.1. China Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

10.2.2. China Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

10.2.3. China Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

10.3. Japan

10.3.1. Japan Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

10.3.2. Japan Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

10.3.3. Japan Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

10.4. India

10.4.1. India Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

10.4.2. India Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

10.4.3. India Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

10.5. Australia

10.5.1. Australia Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

10.5.2. Australia Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

10.5.3. Australia Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

10.6. South Korea

10.6.1. South Korea Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

10.6.2. South Korea Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

10.6.3. South Korea Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

10.7.2. Rest of Asia-Pacific Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

10.7.3. Rest of Asia-Pacific Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Biopharmaceutical CMO and CRO Market By Country

11.1. Latin America Biopharmaceutical CMO and CRO Market Overview

11.2. Brazil

11.2.1. Brazil Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

11.2.2. Brazil Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

11.2.3. Brazil Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

11.3. Mexico

11.3.1. Mexico Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

11.3.2. Mexico Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

11.3.3. Mexico Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

11.4.2. Rest of Latin America Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

11.4.3. Rest of Latin America Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Biopharmaceutical CMO and CRO Market By Country 

12.1. Middle East & Africa Biopharmaceutical CMO and CRO Market Overview

12.2. GCC

12.2.1. GCC Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

12.2.2. GCC Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

12.2.3. GCC Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

12.3. South Africa

12.3.1. South Africa Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

12.3.2. South Africa Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

12.3.3. South Africa Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Source, 2020-2032

12.4.2. Rest of Middle East & Africa Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Service Type, 2020-2032

12.4.3. Rest of Middle East & Africa Biopharmaceutical CMO and CRO Revenue (USD Million) and Forecast By Product, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Biopharmaceutical CMO and CRO Market

13.1. Biopharmaceutical CMO and CRO Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Biopharmaceutical CMO and CRO Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Catalent, Inc.

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2023

14.1.3.2. Catalent, Inc. 2023 Biopharmaceutical CMO and CRO Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Lonza Group AG

14.3. Patheon N.V.

14.4. Thermo Fisher Scientific Inc.

14.5. WuXi AppTec Co., Ltd.

14.6. Samsung Biologics

14.7. Boehringer Ingelheim GmbH

14.8. Cytovance Biologics, Inc.

14.9. AbbVie Contract Manufacturing

14.10. Fujifilm Diosynth Biotechnologies

14.11. AGC Biologics